Polygenic risk impacts lifetime risk and prognosis of glaucoma
Listen to this summary
The authors aimed to evaluate the clinical utility of a glaucoma polygenic risk score (PRS) in assessing glaucoma risk, age at onset, and prognosis in a large cohort of individuals. They found that the best-performing PRS significantly stratified lifetime glaucoma risk and correlated with the need for more intensive glaucoma care, outperforming family history alone. These results suggest that PRS could enhance screening and management strategies for glaucoma, warranting further prospective studies.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More in Ophthalmology
View all →Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · American journal of ophthalmology
No-History IOL Power Calculation After Myopic Laser Vision Correction: A Multicenter Retrospective Database Study of 14 Formulas With and Without Posterior Corneal Curvature
Aug 5, 2026 · The New England journal of medicine
Syncope
Aug 5, 2026 · American journal of ophthalmology
Neighborhood Socioeconomic Deprivation and Adherence to Diabetic Retinopathy Screening Guidelines
Aug 4, 2026 · American journal of ophthalmology
In Vivo Microscopic Assessment of Ocular Surface Changes Induced by Antiglaucoma Medications
Aug 4, 2026 · American journal of ophthalmology
Optical coherence tomography-guided focal navigated laser photocoagulation in central serous chorioretinopathy: a non-inferiority study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


